Pan-European Affidea Group acquires Fortius Clinic

Giuseppe Recchi, CEO, Affidea Group

Europe’s largest medical services provider, Affidea Group, has entered the UK healthcare market with the acquisition of orthopaedic and sports injury specialist Fortius Clinic.

Financial details of the transaction have not been disclosed but the deal is expected to fuel further expansion for London-based Fortius, which has grown rapidly since its launch in 2009.

Affidea Group is owned by interests associated with the Bertarelli family advised by their business enterprise, Waypoint Capital. It currently operates 280 centres across 15 countries in Europe providing diagnostic imaging, outpatient and cancer care services.

Affidea Group CEO Giuseppe Recchi said the acquisition represented a significant step in the company’s growth journey, demonstrating its strategic ambition to expand into new markets.

‘I am thrilled to welcome the Fortius team to the Affidea Group,’ he said. ‘Fortius is a patient-centric organisation whose values and standards of care greatly impressed me. Despite the current critical environment for the national healthcare systems across the world due to Covid-19 pandemic, we will continue to offer outstanding patient care with positive medical outcomes. We will combine Fortius’ excellence and innovation in orthopedic and musculoskeletal care with Affidea’s world-class clinical standards in order to empower our patients to live a life free from pain and injury.’

Fortius is one of the ‘super-specialty’ private healthcare providers which have carved out a new market in central London over the last decade. As well as focusing on orthopaedics and MSK, it has made a name for itself in elite sport and is an accredited FIFA Centre of Excellence.

It operates diagnostic and treatment centres in London’s Fitzhardinge Street and King William Street, along with an ambulatory surgery centre in Bentinck Street and a surgical partnership with Bupa Cromwell Hospital. More recently, it opened a £4.5m outpatient diagnostic and treatment centre in Wimbledon, South London.

CEO Jim McAvoy said the acquisition marked ‘an exciting and pivotal stage in the further growth and development of Fortius’.

‘We are proud of our achievements in the orthopaedic and MSK market over the last 12 years and we look forward to a new chapter for the company as part a powerful European group,’ he said. ‘In Affidea we saw a partner with shared values and a commitment to world class care, innovation and first class service. A reputation for excellence is at the heart of what we do and we will continue to drive forward the Fortius brand, expand our consultant collective, and embed our model of employee engagement, business innovation and clinical leadership – the Fortius Way. We are delighted to be part of the Affidea Group, and look forward to working together on opportunities to grow our presence in the UK and across Europe.’